Samrat Pharmachem Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 616.74 million compared to INR 838.46 million a year ago. Revenue was INR 620.95 million compared to INR 841.26 million a year ago. Net income was INR 3.44 million compared to INR 20.96 million a year ago. Basic earnings per share from continuing operations was INR 1.11 compared to INR 6.78 a year ago.
For the nine months, sales was INR 1,988.99 million compared to INR 2,414.65 million a year ago. Revenue was INR 1,999.84 million compared to INR 2,419.14 million a year ago. Net income was INR 7.67 million compared to INR 173.75 million a year ago. Basic earnings per share from continuing operations was INR 2.48 compared to INR 56.24 a year ago.